The Valley Desk

NCT03441360 · Interventional trial

Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)

Overall registry status Completed

Phase 2

Conditions Ewing Sarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma, Relapsed/Refractory Rhabdomyosarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov